$ENZN has PE Ratio of 2.00 and Uncle Carl Icahn ha
Post# of 98044
Undervalued to say the least.
Coming back to Enzon Pharmaceuticals Inc (NASDAQ:ENZN), whose stake in Icahn’s equity portfolio remained unchanged during the fourth quarter at 5.9 million shares valued at $6.44 million. The $46.39 million company is currently waiting to be acquired by another concern as it has put brakes on the clinical research and is instead banking on royalty revenues from its drug PegIntron, which is marketed by Merck & Co., Inc. (NYSE:MRK). This makes the company an interesting merger arbitrage opportunity for hedge funds. Billionaire Jim Simmons’ Renaissance Technologies increased its stake in the company by 15% during the fourth quarter to 1.81 million shares.
Read more at http://www.insidermonkey.com/blog/voltari-cor...a3dJxId.99
My Favorite Paid chat room with amazing chart setups is The Trading Stock Lounge http://www.thetradingstocklounge.com/